We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Ropes & Gray Reps Axcan In $583M Eurand Deal

Law360 (December 1, 2010, 1:19 PM EST) -- Pharmaceutical company Axcan Holdings Inc. announced plans Wednesday to acquire rival Eurand NV for approximately $583 million, or $12 per share.

Pursuant to the terms of the agreement, a subsidiary of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.